ELOXX PHARMACEUTICALS, INC. (ELOX) Current Ratio
- Current ratio · latest quarter: Value 3.74×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.74× | Current assets / current liabilities. $63.39M ÷ $16.97M ≈ 3.74× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 63.39M USD | Assets, Current |
| Current obligations | 16.97M USD | Liabilities, Current |
| Cash and equivalents | 61.96M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 3.03M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $63.39M | $16.97M | $61.96M | (m) | (m) | (m) | $3.03M | $0.00 | 3.74× |
| 2026-03-31 | $8.50M | $16.09M | $6.36M | (m) | (m) | (m) | $3.03M | $0.00 | 0.53× |
| 2025-12-31 | $5.27M | $17.18M | $4.79M | (m) | (m) | (m) | $2.71M | $1.00M | 0.31× |
| 2024-12-31 | $2.98M | $27.31M | $111.00K | (m) | (m) | (m) | $5.35M | $6.52M | 0.11× |
| 2023-12-31 | $1.55M | $22.70M | $1.13M | (m) | (m) | (m) | $5.70M | $2.22M | 0.07× |
| 2023-09-30 | $5.63M | $23.47M | $4.78M | (m) | (m) | (m) | $3.13M | $2.82M | 0.24× |
| 2023-06-30 | $5.38M | $21.25M | $4.33M | (m) | (m) | (m) | $3.12M | $2.28M | 0.25× |
| 2023-03-31 | $6.40M | $19.46M | $4.90M | (m) | (m) | (m) | $2.43M | $1.54M | 0.33× |
| 2022-12-31 | $20.13M | $23.09M | $19.21M | (m) | (m) | (m) | $3.02M | $3.98M | 0.87× |
| 2022-09-30 | $25.67M | $21.68M | $24.55M | (m) | (m) | (m) | $1.59M | $2.53M | 1.18× |
| 2022-06-30 | $31.59M | $19.50M | $30.05M | (m) | (m) | (m) | $1.93M | $1.13M | 1.62× |
| 2022-03-31 | $42.15M | $19.17M | $39.77M | (m) | (m) | (m) | $2.90M | (m) | 2.20× |
| 2021-12-31 | $43.48M | $9.96M | $42.27M | (m) | (m) | (m) | $1.38M | $0.00 | 4.37× |
| 2021-09-30 | $53.54M | $9.51M | $52.43M | (m) | (m) | (m) | $2.51M | (m) | 5.63× |
| 2021-06-30 | $58.56M | $15.21M | $56.73M | (m) | (m) | (m) | $2.02M | $5.69M | 3.85× |
| 2021-03-31 | $19.96M | $12.69M | $18.25M | (m) | (m) | (m) | $485.00K | $5.56M | 1.57× |
| 2020-12-31 | $25.89M | $9.84M | $24.67M | (m) | (m) | (m) | $481.00K | $5.24M | 2.63× |
| 2020-09-30 | $32.21M | $9.98M | $30.59M | (m) | (m) | (m) | $638.00K | $4.92M | 3.23× |
| 2020-06-30 | $38.97M | $10.77M | $30.35M | $6.77M | (m) | (m) | $770.00K | $5.15M | 3.62× |
| 2020-03-31 | $45.93M | $11.08M | $25.88M | $18.08M | (m) | (m) | $1.39M | $4.77M | 4.14× |
| 2019-12-31 | $57.71M | $11.81M | $22.49M | $33.78M | (m) | (m) | $1.87M | $4.34M | 4.89× |
| 2019-09-30 | $66.85M | $11.23M | $22.16M | $42.78M | (m) | (m) | $1.69M | $3.49M | 5.95× |
| 2019-06-30 | $77.74M | $10.99M | $49.33M | $26.97M | (m) | (m) | $2.47M | $2.23M | 7.07× |
| 2019-03-31 | $55.46M | $8.42M | $44.58M | $8.93M | (m) | (m) | $2.24M | $984.00K | 6.58× |
| 2018-12-31 | $50.34M | $7.81M | $48.61M | (m) | (m) | (m) | $747.00K | (m) | 6.45× |
| 2018-09-30 | $56.14M | $5.08M | $55.34M | (m) | (m) | (m) | $1.35M | (m) | 11.05× |
| 2018-06-30 | $63.97M | $4.36M | $63.41M | (m) | (m) | (m) | $2.10M | (m) | 14.69× |
| 2018-03-31 | $18.84M | $5.65M | $18.29M | (m) | (m) | (m) | $2.17M | (m) | 3.33× |
| 2017-12-31 | $24.51M | $3.42M | $24.05M | (m) | (m) | (m) | $1.53M | (m) | 7.16× |
| 2017-09-30 | $1.04M | $1.08M | $957.87K | (m) | (m) | (m) | $108.57K | (m) | 0.96× |
| 2017-06-30 | $284.42K | $2.77M | $33.20K | (m) | (m) | (m) | $191.60K | (m) | 0.10× |
| 2017-03-31 | $272.26K | $1.06M | $241.95K | (m) | (m) | (m) | $109.15K | (m) | 0.26× |
| 2016-12-31 | $3.09M | $2.52M | $2.21M | (m) | (m) | (m) | $1.90M | (m) | 1.23× |
| 2016-09-30 | $375.91K | $467.27K | $287.06K | (m) | (m) | (m) | $144.87K | (m) | 0.80× |
| 2016-06-30 | $982.63K | $368.99K | $810.81K | (m) | (m) | (m) | $90.31K | (m) | 2.66× |
| 2016-03-31 | $1.60M | $377.35K | $1.53M | (m) | (m) | (m) | $56.60K | (m) | 4.25× |
| 2015-12-31 | $2.69M | $569.15K | $2.37M | (m) | (m) | (m) | $63.50K | (m) | 4.72× |
| 2015-09-30 | $3.65M | $675.49K | $3.35M | (m) | (m) | (m) | $174.36K | (m) | 5.41× |
| 2015-06-30 | $3.73M | $778.52K | $3.33M | (m) | (m) | (m) | $232.03K | (m) | 4.79× |
| 2015-03-31 | $598.15K | $1.66M | $469.98K | (m) | (m) | (m) | $656.47K | (m) | 0.36× |
| 2014-12-31 | $2.37M | $2.55M | $2.11M | (m) | $203.91K | (m) | $1.31M | (m) | 0.93× |
| 2014-09-30 | $4.04M | $1.69M | $3.84M | (m) | $43.13K | (m) | $613.02K | (m) | 2.40× |
| 2014-06-30 | $7.22M | $1.83M | $6.11M | (m) | $43.13K | (m) | $901.18K | (m) | 3.96× |
| 2014-03-31 | $7.40M | $1.06M | $6.20M | (m) | (m) | (m) | $324.94K | (m) | 7.01× |
| 2013-12-31 | $7.61M | $3.28M | $6.12M | (m) | (m) | (m) | $477.63K | (m) | 2.32× |
| 2013-09-30 | $2.36M | $3.60M | $789.18K | (m) | (m) | (m) | $1.00M | (m) | 0.65× |
| 2013-06-30 | $3.52M | $3.21M | $1.60M | (m) | $0.00 | (m) | $637.32K | (m) | 1.10× |
| 2013-03-31 | $3.29M | $3.22M | $1.58M | (m) | (m) | (m) | $686.95K | (m) | 1.02× |
| 2012-12-31 | $1.94M | $3.75M | $640.13K | (m) | (m) | (m) | $1.09M | (m) | 0.52× |
| 2012-09-30 | $2.77M | $3.44M | $1.31M | (m) | (m) | (m) | $932.17K | (m) | 0.81× |
| 2012-06-30 | $3.55M | $3.16M | $2.00M | (m) | (m) | (m) | $594.51K | (m) | 1.12× |
| 2012-03-31 | $4.94M | $3.53M | $3.21M | (m) | (m) | (m) | $804.78K | (m) | 1.40× |
| 2011-12-31 | $3.21M | $3.45M | $1.55M | (m) | (m) | (m) | $443.75K | (m) | 0.93× |
| 2011-09-30 | $4.67M | $3.80M | $2.84M | (m) | (m) | (m) | $949.09K | (m) | 1.23× |
| 2011-06-30 | $5.06M | $3.27M | $3.61M | (m) | (m) | (m) | $559.52K | (m) | 1.55× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |